Velan Capital Master Fund Lp - Net Worth and Insider Trading
Velan Capital Master Fund Lp Net Worth
The estimated net worth of Velan Capital Master Fund Lp is at least $32 Million dollars as of 2024-11-05. Velan Capital Master Fund Lp is the of Jasper Therapeutics Inc and owns about 1,433,828 shares of Jasper Therapeutics Inc (JSPR) stock worth over $32 Million. Details can be seen in Velan Capital Master Fund Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Velan Capital Master Fund Lp has not made any transactions after 2024-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Velan Capital Master Fund Lp
Velan Capital Master Fund Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Velan Capital Master Fund Lp owns 3 companies in total, including Heron Therapeutics Inc (HRTX) , Jasper Therapeutics Inc (JSPR) , and Alimera Sciences Inc (ALIM) .
Click here to see the complete history of Velan Capital Master Fund Lp’s form 4 insider trades.
Insider Ownership Summary of Velan Capital Master Fund Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2023-01-30 | other: See Footnote 2 |
| JSPR | Jasper Therapeutics Inc | 2024-02-08 | other: See Footnote 1 |
| ALIM | Alimera Sciences Inc | 2023-05-17 | 10 percent owner |
Velan Capital Master Fund Lp Latest Holdings Summary
Velan Capital Master Fund Lp currently owns a total of 1 stock. Velan Capital Master Fund Lp owns 1,433,828 shares of Jasper Therapeutics Inc (JSPR) as of February 8, 2024, with a value of $32 Million.
Latest Holdings of Velan Capital Master Fund Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics Inc | 2024-02-08 | 1,433,828 | 22.49 | 32,246,792 |
Holding Weightings of Velan Capital Master Fund Lp
Velan Capital Master Fund Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Velan Capital Master Fund Lp has made a total of 1 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Jasper Therapeutics Inc is the acquisition of 350,000 shares on February 8, 2024, which cost Velan Capital Master Fund Lp around $5 Million.
Insider Trading History of Velan Capital Master Fund Lp
- 1
Velan Capital Master Fund Lp Trading Performance
GuruFocus tracks the stock performance after each of Velan Capital Master Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Velan Capital Master Fund Lp is 22.06%. GuruFocus also compares Velan Capital Master Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Velan Capital Master Fund Lp within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Velan Capital Master Fund Lp's insider trading performs compared to the benchmark.
Performance of Velan Capital Master Fund Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 58.7 |  | | | | |
| Relative Return to S&P 500(%) | 56.18 | | | | | |
Velan Capital Master Fund Lp Ownership Network
Ownership Network List of Velan Capital Master Fund Lp
Ownership Network Relation of Velan Capital Master Fund Lp
Velan Capital Master Fund Lp Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Velan Capital Master Fund Lp is the other: See Footnote 2 of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Velan Capital Master Fund Lp made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Velan Capital Master Fund Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Velan Capital Master Fund Lp. You might contact Velan Capital Master Fund Lp via mailing address: 1055b Powers Place, Alpharetta Ga 30009.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
